Our development activities utilize our technology platform
for New Chemical Entities (NCE) or existing drug molecules
that can benefit from our technology.
Our current product portfolio consists of products in Gastro
Intestinal (GI), Cardiovascular (CV), antiviral and
antibacterial, anti fungal and Central Nervous System (CNS)
area.
Following is In-Vitro data for one of our products under the
development for QD dosing. There is an excellent ivivc
correlation for this drug. We will be applying the same
technology to other similar molecules.
copyright Patrin Pharma 2005-2009
for New Chemical Entities (NCE) or existing drug molecules
that can benefit from our technology.
Our current product portfolio consists of products in Gastro
Intestinal (GI), Cardiovascular (CV), antiviral and
antibacterial, anti fungal and Central Nervous System (CNS)
area.
Following is In-Vitro data for one of our products under the
development for QD dosing. There is an excellent ivivc
correlation for this drug. We will be applying the same
technology to other similar molecules.
copyright Patrin Pharma 2005-2009
| TECHNOLOGY |
 |
| |
 |
| |
 |
| |
 |
| |
 |
